These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9378843)

  • 1. Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration.
    Burstein AH; Modica R; Hatton M; Forrest A; Gengo FM
    J Clin Pharmacol; 1997 Aug; 37(8):711-8. PubMed ID: 9378843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers.
    Knoester PD; Jonker DM; Van Der Hoeven RT; Vermeij TA; Edelbroek PM; Brekelmans GJ; de Haan GJ
    Br J Clin Pharmacol; 2002 May; 53(5):501-7. PubMed ID: 11994056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacokinetic and pharmacodynamic study, in healthy volunteers, of a rapidly absorbed intranasal midazolam formulation.
    Wermeling DP; Record KA; Archer SM; Rudy AC
    Epilepsy Res; 2009 Feb; 83(2-3):124-32. PubMed ID: 19046855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: Randomized study in healthy geriatric and non-geriatric adults.
    Berg AK; Myrvik MJ; Van Ess PJ
    Epilepsy Behav; 2017 Jun; 71(Pt A):51-59. PubMed ID: 28544992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flumazenil reduces midazolam-induced cognitive impairment without altering pharmacokinetics.
    Rogers JF; Morrison AL; Nafziger AN; Jones CL; Rocci ML; Bertino JS
    Clin Pharmacol Ther; 2002 Dec; 72(6):711-7. PubMed ID: 12496752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping.
    Lee JI; Chaves-Gnecco D; Amico JA; Kroboth PD; Wilson JW; Frye RF
    Clin Pharmacol Ther; 2002 Dec; 72(6):718-28. PubMed ID: 12496753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal midazolam in piglets: pharmacodynamics (0.2 vs 0.4 mg/kg) and pharmacokinetics (0.4 mg/kg) with bioavailability determination.
    Lacoste L; Bouquet S; Ingrand P; Caritez JC; Carretier M; Debaene B
    Lab Anim; 2000 Jan; 34(1):29-35. PubMed ID: 10759364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midazolam pharmacokinetics following intravenous and buccal administration.
    Schwagmeier R; Alincic S; Striebel HW
    Br J Clin Pharmacol; 1998 Sep; 46(3):203-6. PubMed ID: 9764959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of midazolam given as an intranasal spray to adult surgical patients.
    Björkman S; Rigemar G; Idvall J
    Br J Anaesth; 1997 Nov; 79(5):575-80. PubMed ID: 9422893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of midazolam after intravenous and intramuscular administration in alpacas.
    Aarnes TK; Fry PR; Hubbell JA; Bednarski RM; Lerche P; Chen W; Bei D; Liu Z; Lakritz J
    Am J Vet Res; 2013 Feb; 74(2):294-9. PubMed ID: 23363357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of a new highly concentrated intranasal midazolam formulation for conscious sedation.
    Schrier L; Zuiker R; Merkus FW; Klaassen ES; Guan Z; Tuk B; van Gerven JM; van der Geest R; Groeneveld GJ
    Br J Clin Pharmacol; 2017 Apr; 83(4):721-731. PubMed ID: 27780297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam.
    Palkama VJ; Ahonen J; Neuvonen PJ; Olkkola KT
    Clin Pharmacol Ther; 1999 Jul; 66(1):33-9. PubMed ID: 10430107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
    Gorski JC; Jones DR; Haehner-Daniels BD; Hamman MA; O'Mara EM; Hall SD
    Clin Pharmacol Ther; 1998 Aug; 64(2):133-43. PubMed ID: 9728893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of midazolam following intravenous and intramuscular administration to sheep.
    Simon BT; Scallan EM; O O; Ebner LS; Cerullo MN; Follette C; Cox SK; Doherty TJ; Lizarraga I
    Am J Vet Res; 2017 May; 78(5):539-549. PubMed ID: 28441044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal midazolam: pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteers.
    Hardmeier M; Zimmermann R; Rüegg S; Pflüger M; Deuster S; Suter K; Donzelli M; Drewe J; Krähenbühl S; Fuhr P; Haschke M
    Clin Pharmacol Ther; 2012 May; 91(5):856-62. PubMed ID: 22453191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
    Dingemanse J; van Gerven JM; Schoemaker RC; Roncari G; Oberyé JJ; van Oostenbruggen MF; Massarella J; Segala P; Zell M; Cohen AF
    Br J Clin Pharmacol; 1997 Nov; 44(5):477-86. PubMed ID: 9384465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of a novel midazolam gel after intranasal administration in dogs.
    Eagleson JS; Platt SR; Strong DL; Kent M; Freeman AC; Nghiem PP; Zheng B; White CA
    Am J Vet Res; 2012 Apr; 73(4):539-45. PubMed ID: 22452501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal midazolam plasma concentration profile and its effect on anxiety associated with dental procedures.
    Burstein AH; Modica R; Hatton M; Gengo FM
    Anesth Prog; 1996; 43(2):52-7. PubMed ID: 10323126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of parecoxib, a parenteral cyclooxygenase-2 specific inhibitor, on the pharmacokinetics and clinical effects of midazolam.
    Ibrahim A; Karim A; Feldman J; Kharasch E
    Anesth Analg; 2002 Sep; 95(3):667-73, table of contents. PubMed ID: 12198057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.